Related Experiment Videos
Retinal vascular permeability determined by dual-tracer fluorescence angiography
P K Russ1, G M Gaylord, F R Haselton
1Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37235, USA.
Annals of Biomedical Engineering
|September 15, 2001
Summary
A new dual-tracer fluorescence angiography method quantitatively assesses the blood-retinal barrier. This technique is sensitive to changes caused by hyperosmolar mannitol, offering a promising tool for tracking retinal vascular permeability.
Area of Science:
- Ophthalmology
- Vascular Biology
- Biomedical Engineering
Background:
- Diabetic retinopathy is a leading cause of blindness in working-age adults.
- Early breakdown of the blood-retinal barrier is a key event in diabetic retinopathy progression.
- Current methods for assessing the retinal vascular barrier in vivo are limited in sensitivity and quantitation.
Purpose of the Study:
- To develop and validate a quantitative method for assessing the retinal vascular barrier in vivo.
- To evaluate the sensitivity of the developed method to changes induced by hyperosmolar stimuli.
Main Methods:
- Combined fluorescence microangiography with simultaneous use of two fluorescent tracers.
- Adapted indicator dilution techniques to quantitatively assess retinal vasculature in Long Evans rats.
- Measured permeability-surface area over flow (PS/F) and estimated sodium fluorescein permeability.
Main Results:
- Established a baseline PS/F of 0.086+/-0.031 in Long Evans rat retinal vasculature.
- Estimated sodium fluorescein permeability to be approximately 1.2 x 10(-5) cm/s.
- Demonstrated that a 1.6 M mannitol infusion significantly increased PS/F, indicating increased blood-retinal barrier permeability.
Conclusions:
- Dual-tracer fluorescence angiography is a sensitive, quantitative method for assessing the retinal vascular barrier in vivo.
- The method can detect increases in blood-retinal barrier permeability induced by hyperosmolar mannitol.
- This minimally invasive technique holds promise for quantitatively tracking retinal vascular permeability changes in disease states.